HVIVO PLC — Director's Dealing 2014

May 27, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1425I

Venn Life Sciences Holdings PLC

27 May 2014

27 May 2014                                 Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Director's Dealing

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that David Evans, a director, has today purchased 210,000 ordinary shares of 0.1 pence each in the Company at a price of 20.5 pence per share.

David Evans now holds 289,033 ordinary shares of 0.1 pence each, representing 1.03 per cent. of the Company's issued share capital.

Enquiries:
Venn Life Sciences Holdings Plc
Tony Richardson, Chief Executive Officer	Tel: +353 154 99 341
Zeus Capital Limited (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones (Corporate Finance)	Tel: 0161 831 1512
Dominic Wilson (Institutional Sales)	Tel: 020 7533 7727
Walbrook PR Ltd Paul McManus	Tel: 020 7933 8787 or venn@walbrookpr.com Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBXGDUXDDBGSR